Strategy and Efficacy of Generic and Pangenotypic SOFOSBUVIR/VELPATASVIR in Chronic HCV: A Myanmar Experience

ConclusionsIn Myanmar, generic and pangenotypic SOF/VEL +/- RBV is a highly effective and safe treatment for HCV regardless of HCV genotype and therefore the requirement for baseline genotype can be eliminated. Future strategies should include elimination of on treatment and end of treatment HCV RNA testing to enhance treatment uptake and further reduce cost.
Source: Journal of Clinical and Experimental Hepatology - Category: Gastroenterology Source Type: research